Table 1. Stakeholder characteristics.
Academic Partners (n = 7) | Country | Expertise |
South Africa | Vaccinology | |
South Africa | Vaccinology | |
Kenya | Obstetrics and Gynecology | |
UK* | Vaccine epidemiology | |
UK* | Economics and health systems | |
Zambia | Health promotion and public policy | |
Nigeria | Health promotion | |
Global Immunization Partners (n = 6) | Region | Expertise |
WHO | AFR, EUR | Vaccine preventable diseases and immunization |
UNICEF | AFR | Health promotion |
GAVI | AFR | Global health policy |
BMGF | AFR | Health policy and finance, public health economics |
IARC | AFR, EUR, AMR | Obstetrics and Gynecology, cancer prevention |
PATH | AFR, SEAR, WPR | Immunization programs |
*Participants based in the UK had sustained programs of research in LMICs